MT-4666

DRUG2 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Alzheimer's Disease

Phase 2

Safety and Efficacy of MT-4666

CompletedNCT01764243

Tanabe Pharma CorporationAlzheimer's Disease

Start: 2012-11-30End: 2015-07-31Updated: 2015-09-28

Phase 3

Safety Study of MT-4666 in Subjects With Alzheimer's Disease

TerminatedNCT02327182

Tanabe Pharma CorporationAlzheimer's Disease

Start: 2014-12-31End: 2015-10-31Updated: 2015-11-13